Objective: To determine the efficacy and dermal tolerance of a novel alcohol-based skin antiseptic (ABSA) in horses.
Study Design: Experimental study.
Animal Population: Systemically healthy horses (n = 25) with no history or clinical signs of skin disease.
Methods: Four clipped sites on the abdomen were randomly assigned to a skin preparation protocol: saline (negative control; NC), chlorhexidine gluconate followed by isopropyl alcohol (positive control; PC), saline followed by the ABSA (ABSA A), or a commercially available horse shampoo followed by the ABSA (ABSA B). Microbiological swabs were obtained from each site and cultured on MacConkey and mannitol salt agar plates. Colony-forming units were counted 18-24 hours later. All sites were scored for signs of skin reaction before, immediately after, 1 hour after, and 24 hours after skin preparation.
Results: The PC, ABSA A, and ABSA B methods reduced skin microbial burden compared with the NC method (P < .001), but no difference was detected between antiseptic products. Preparation time did not differ between ABSA A and ABSA B methods (P = 0.108); both were faster than the PC method (P < 0.001 for both). Skin reactions were most abundant 24 hours after skin preparation (30.5%), but there was no significant association with antiseptic used, and no horses required veterinary treatment.
Conclusion: The ABSA preparations tested in this study were as effective and well tolerated as a chlorhexidine gluconate-based method, but required less time in healthy horses.
Clinical Significance: The ABSA tested here provides an efficacious, fast-acting, and well-tolerated alternative to achieve skin antisepsis in healthy horses. These results justify further investigation in clinical cases.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/vsu.12793 | DOI Listing |
Pharmaceutics
December 2024
College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.
In addition to oncological applications, poly(ADP-ribose) polymerase (PARP) inhibitors have potential as anti-inflammatory agents. Colon-targeted delivery of PARP inhibitors has been evaluated as a pharmaceutical strategy to enhance their safety and therapeutic efficacy against gut inflammation. Colon-targeted PARP inhibitors 5-aminoisoquinoline (5-AIQ) and 3-aminobenzamide (3-AB) were designed and synthesized by azo coupling with salicylic acid (SA), yielding 5-AIQ azo-linked with SA (AQSA) and 3-AB azo-linked with SA (ABSA).
View Article and Find Full Text PDFData Brief
December 2024
Department of Computer Science and Engineering, Khulna University of Engineering & Technology, Khulna 9203, Bangladesh.
Sentiment analysis is becoming rapidly important for exploring social media Bangla text. The lack of sufficient resources is considered to be an important challenge for Aspect Based Sentiment Analysis (ABSA) of the Bangla language. The ABSA is a technique that divides the text and defines its sentiment based on its aspects.
View Article and Find Full Text PDFHealth Secur
November 2024
Syra Madad, DHSc, MSc, MCP, CHEP, is Senior Director, System-Wide Special Pathogens Program, Emergency Management, NYC Health + Hospitals (H+H), New York, NY. Jessica L. Jacobson, MD, is Laboratory Director and Chief of Pathology, NYC H+H/Bellevue, and a Clinical Professor of Pathology, Department of Pathology, NYU Grossman School of Medicine; both in New York, NY. Rebecca R. Caruso, MPH, RBP, CBSP (ABSA), CAGS, is Director, Committee on Microbiological Safety, Harvard Medical School, Boston, MA. Jake Dunning, MBBS, MRCP, DIC, PhD, is a Consultant, Department of Infectious Diseases, Royal Free Hospital, London, and a Senior Research Fellow, Pandemic Sciences Institute, University of Oxford, Oxford, United Kingdom.
J Hosp Infect
January 2025
Department of Hospital Infection Management, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address:
Background: Personnel in clinical microbiology laboratories face heightened risks of occupational infections, due to the potential for pathogenicity in clinical samples.
Aim: To summarize the characteristics of laboratory-acquired infections (LAIs) and review exposure incidents in clinical laboratories, and to conduct a meta-analysis to estimate post-exposure incidence rates and evaluate the efficacy of post-exposure prophylaxis (PEP) following Brucella exposures.
Methods: A systematic search across PubMed, Embase, Web of Science, CNKI, Wanfang, CMB, and the ABSA LAI database extracted relevant literature published from January 1, 1990, to August 31, 2023, including case reports and laboratory exposure risk events.
Sci Rep
October 2024
School of Electronic Information Engineering, Geely University of China, Chengdu, 641423, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!